Catheter Precision Expands U.S. Customer Base for VIVOâ„¢ for Non-invasive Arrythmia Location Detection Before Ventricular Ablation Procedures
businesswire.com
news
2022-10-20 00:00:00

MT. OLIVE, N.J. & CARLSBAD, Calif.--(BUSINESS WIRE)--Catheter Precision, Inc. ('Catheter Precision'), a medical device company focused on cardiac electrophysiology, announces receipt of three commercial orders in the past 60 days as usage of the device continues to increase in the U.S. On September 12, 2022 privately held Catheter Precision announced a definitive merger agreement with Ra Medical Systems (NYSE American: RMED), which, if completed, will result in a combined publicly traded company focusing on the cardiac electrophysiology market.
